IMPROVE

Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare
Project ID
Funding Organization:
Funding Programme:
HORIZON-JU-IHI-2022-03-02 (Horizon Europe – IHI JU)
Funding Instrument:
RIA (Research and Innovation Action)
Start Date:
01/12/2023
Duration:
60 months
Total Budget:
17,115,801 EUR
ITI Budget:
54,187 EUR
Scientific Responsible:

The IMPROVE project uses Patient Generated Health Data (PGHD) gathered via m-health and e-health technologies to gain improved insights into the real-life behaviour and challenges of patients of all ages with complex, chronic diseases and comorbidities. The IMPROVE platform will enable the smart use of patient input and patient generated evidence to (1) advance the role of patient preference and experience in treatment selection, (2) improve medical device design based on patient preferences and experiences, and (3) facilitate faster market entry of patient-centric and cost-effective integrated care solutions. Improved clinical adoption of Value Based Health Care will be demonstrated across the EU in 10 use cases in at least 5 disease areas (e.g. ophthalmology, oncology, cardiovascular disease, chronic inflammation, neurology), using a design thinking approach and a significant contribution from implementation science.

CERTH (through ITI) takes part in WP1 (management), WP5 (use cases for validation) and WP8 (exploitation, communication and dissemination). In WP5 it implements in Greece, together with ROCHE, the cardiovascular case study (Task 5.4), based on KardioUp, a novel mHealth system for heart failure patients that monitors treatment adherence and physiological and environmental variables and provides personalised guidance through a prediction engine. It also contributes to the study design and KPI definition of the use cases (Task 5.1).

Consortium

Universidad Politécnica de Madrid (UPM), Spain (Coordinator)
PredictBy Research and Consulting S.L. (PBY), Spain
Lægemiddelstyrelsen – Danish Medicines Agency (DKMA), Denmark
F. Hoffmann-La Roche AG (ROCHE), Switzerland
Institut za ekonomska raziskovanja (IER), Slovenia
Institut for Fremtidsforskning (CIFS), Denmark
Fundació Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Spain
Philips Medical Systems Nederland BV (PMS), Netherlands
Heinrich-Heine-Universität Düsseldorf (UDUS), Germany
Tilburg University (TiU), Netherlands
Dedalus Italia S.p.A. (DEDALUS), Italy
Fondazione Italiana Sclerosi Multipla – FISM ETS (FISM), Italy
Agenzia Regionale per la Salute ed il Sociale (AReSS Puglia), Italy
Multimed Engineers Srl (MME), Italy
Iserundschmidt GmbH (ius), Germany
Better Programska Oprema d.o.o. (Better ltd), Slovenia
Stichting Het Nederlands Kanker Instituut – Antoni van Leeuwenhoek Ziekenhuis (NKI AVL), Netherlands
Fachhochschule St. Pölten GmbH (St. Pölten UAS), Austria
Univerzitetni klinični center Ljubljana (UKCL), Slovenia
Universiteit Utrecht (UU), Netherlands
Medtronic Ibérica SA (MEDTRONIC), Spain
Fundació Hospital Universitari Vall d’Hebron – Institut de Recerca (VHIR), Spain
Splošna bolnišnica Celje (GH CELJE), Slovenia
Ortopedska bolnišnica Valdoltra (OBV), Slovenia
Ethniko Kentro Erevnas kai Technologikis Anaptyxis (CERTH), Greece
Philips GmbH (PMIA), Germany
UDG Alliance, Switzerland (associated partner)

Contact

Dr. Konstantinos Votis
(Scientific Responsible)
Building A - Office 2.8

Information Technologies Institute
Centre of Research & Technology - Hellas
6th km Harilaou - Thermis, 57001, Thermi - Thessaloniki
Tel.: +30 2311 257722
Fax: +30 2310 474128
Email: kvotis@iti.gr